The RF model predicted the active or inactive SLE phase through analysis of biomarkers, including cytokines, cytotoxic molecules, and traditional markers such as C3, C4, and anti-dsDNA (SLEDAI-2K parameters). The gene discussed is C4A; the disease is systemic lupus erythematosus.